This year, Homart Pharmaceuticals has been supported by “Investment NSW” to continue partaking in this meaningful event. Although we were not able to personally exhibit at the expo this year, we were represented by the NSW government at their stand. Homart was able to continue to showcase as a leading company in brand marketing and manufacturing for Australian-made and designed health supplements, skincare and dairy products.
The Middle East and North Africa region will continue to be shaped by increasing public-private partnerships in their expanding health sector. With over 12 brands across Homart’s portfolio, most of the products are sold worldwide: UAE (including Iran and Jordan), Australia, America, China and Asean regions. Our strategic key partners in Dubai, are one of the largest pharmacy chains that show continuous support towards Homart.
Published: 10 February 2022
Homart returns to Arab Health 2022 Expo supported by Investment NSW Government
This year, Homart Pharmaceuticals has been supported by “Investment NSW” to continue partaking in this meaningful event. Although we were not able to personally exhibit at the expo this year, we were represented by the NSW government at their stand. Homart was able to continue to showcase as a leading company in brand marketing and manufacturing for Australian-made and designed health supplements, skincare and dairy products.
The Middle East and North Africa region will continue to be shaped by increasing public-private partnerships in their expanding health sector. With over 12 brands across Homart’s portfolio, most of the products are sold worldwide: UAE (including Iran and Jordan), Australia, America, China and Asean regions. Our strategic key partners in Dubai, are one of the largest pharmacy chains that show continuous support towards Homart.